Approval · Notice of Compliance 29075 · 2022
ALKERAN: Notice of Compliance 29075
Issued September 26, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29075
- Date
- September 26, 2022
- Company
- Aspen Pharmacare Canada Inc.Oakville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety updates to the Product Monograph.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ALKERAN | Not yet assigned | — |
Medicinal ingredients
- MELPHALAN 2 MG per TAB
- BUFFER SOLUTION 10 ML per VIAL
- MELPHALAN 50 MG per VIAL